Conventional vaccines have been very successful in preventing and controlling many diseases. One of the next steps in vaccine innovation is the introduction of genetic modification, which provides various novel opportunities in the vaccine field. Although the market potential for conventional vaccines has been evaluated in detail, the market potential of genetically modified vaccines has not been investigated yet. Interviews with key opinion leaders were conducted to extract critical success factors, which subsequently were quantified, weighed, and prioritised by a ranking survey. Results of this study revealed that critical success factors could be classified into four categories: technical, commercial, rules & regulations, and societal. The key opinion leaders indicated that the category “rules & regulations” requires immediate attention and consideration. Additionally, the “societal potential” category demands intervention measurements, as both these categories included highly prioritised barriers. They further indicated that genetically modified vaccines provide new market opportunities against previously untargeted diseases.
|Journal||International Journal of Innovative Research in Science, Engineering and Technology|
|Publication status||Published - 2016|